Arimidex 1 mg

DRUG2 trials

Sponsors

Centre Leon Berard, AstraZeneca

Conditions

McCune-Albright SyndromePatients with locally advanced or metastatic low grade endometrial stroma sarcoma

Phase 2

Arimidex in McCune Albright Syndrome

CompletedNCT00055302

AstraZenecaMcCune-Albright Syndrome

Start: 2002-08-31End: 2015-08-31Updated: 2015-09-01

BFR ESS - A randomized comparative, prospective, multicentre phase II study evaluating the clinical impact of interruption versus maintenance of aromatase inhibitors in patients with locally advanced or metastatic low grade endometrial stromal sarcoma

RecruitingCTIS2024-512629-97-00

Centre Leon BerardPatients with locally advanced or metastatic low grade endometrial stroma sarcoma

Start: 2019-01-23Target: 40Updated: 2025-06-26